Please try another search
Taihua plc, an investment holding company, develops, manufactures, distributes, and sells traditional Chinese medicine TCM products and active pharmaceutical ingredients APIs in China. The company operates in four segments: Paclitaxel, Homoharringtonine, TCM Products, and Forsythia. Its APIs products include paclitaxel, which is extracted from the bark of the yew tree for the treatment of ovaries, breast, lungs, skin, and mucous membranes cancer; and Homoharringtonine, an alkaloid extracted from branches and leaves of the cephalotaxus tree for the treatment of acute myeloid leukaemia and other cancers. The company also offers TCM products, including gengnianan tablet, duzhong pingya tablet, zaoren anshen keli, bunao anshen tablet, jiangzi jianfei tablet, dabaidu capsule, runing tablet, and bian tong pian. In addition, it cultivates, harvests, and sells Forsythia, a flowering shrub for use as the basis of TCM preparations. The company was formerly known as China Natural Plc and changed its name to Taihua plc in September 2006. Taihua plc was incorporated in 2006 and is based in Xi'an, China.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review